ROIV Stock Analysis: Buy, Sell, or Hold?
ROIV - Roivant Sciences Ltd. Common Shares
$21.62
-0.40 (-1.82%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 09, 2026
8d
Smart Money Accumulation
ROIV is down 4.2% this week, but smart money is accumulating calls. Top strike: $22 2026-03-20 with 525 OI. Call ratio: 100% View Scanner →
Strength: 7.1/10
Get Alerted When ROIV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ROIV shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: ROIV shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: ROIV is currently trading at $21.62, which is considered oversold relative to its 30-day fair value range of $21.72 to $23.00.
Technical Outlook: Technically, ROIV is in a strong uptrend. The price is currently testing key support at $21.50. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $27.00 (+22.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ROIV is in a strong uptrend. The price is currently testing key support at $21.50. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $27.00 (+22.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$21.72 -
$23.00
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.6% below Wall St target ($27.00)
Fair Price Analysis
30-Day Fair Range
$21.72 -
$23.00
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$21.51
Resistance Level
$23.42
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-19.44
Wall Street Target
$27.00
(+22.6%)
Revenue Growth (YoY)
-64.9%
Earnings Growth (YoY)
-96.1%
Last updated: January 31, 2026 9:26 AM ET
Data refreshes hourly during market hours. Next update: 10:26 AM
Data refreshes hourly during market hours. Next update: 10:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ROIV showing a specific setup today?
Insider Activity (6 Months)
1
Buys
15
Sells
Net
INSIDERS SELLING
Recent Transactions
Eric Venker
SELL
118418 shares
2025-10-17
Eric Venker
SELL
318282 shares
2025-10-16
Eric Venker
SELL
414683 shares
2025-10-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced ROIV Option Strategies
Professional options setups generated by AI based on today's ROIV price and gamma walls.
